机构地区:[1]浙江大学医学院附属第二医院大肠外科,浙江杭州310009
出 处:《实用肿瘤杂志》2023年第6期528-536,共9页Journal of Practical Oncology
基 金:国家自然科学基金面上项目(82172851);国家自然科学基金青年项目(82103684,11932017)。
摘 要:目的探究产甲胎蛋白型胃癌(alpha-fetoprotein-producing gastric cancer,AFPGC)细胞中甲胎蛋白(alpha fetoprotein,AFP)表达的调控机制及其与肿瘤细胞恶性生物学行为的关系。方法使用人AFPGC细胞系FU97,采用亚克隆分选技术,建立18个亚克隆细胞株(M1~M18)。Western blot及荧光实时定量聚合酶链反应(real-time quantitative polymerase chain reaction,RT-qPCR)检测AFP表达,挑选出AFP表达最高和最低的2个亚克隆细胞株。通过划痕实验、上皮间质转化(epithelialmesenchymal transition,EMT)分子标志物检测、药物毒性实验及NSG小鼠皮下成瘤实验比较2个亚克隆细胞株的恶性生物学行为。应用RNA-seq检测FU97-AFP^(High)和FU97-AFP^(Low)细胞的差异表达基因,同时京都基因与基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)富集分析关键信号通路改变,并使用Yes关联蛋白1(Yes-associated protein 1,YAP1)小分子抑制剂verteporfin干预实验进行验证。结果Western blot显示,FU97细胞不同亚克隆株AFP的表达水平差异大,亚克隆株M8和M12分别有最低和最高的AFP蛋白表达量。RT-qPCR显示,AFP高表达细胞株M12(FU97-AFP^(High))和AFP低表达细胞株M8(FU97-AFP^(Low))的AFP表达量分别为(38.70±3.37)和(3.33±0.04),差异具有统计学意义(P<0.01)。FU97-AFP^(High)细胞的迁移能力大于FU97-AFP^(Low)细胞(P<0.01),且高表达N-cadherin,低表达E-cadherin。细胞毒性实验表明,FU97-AFP^(High)细胞对5-氟尿嘧啶、多西他赛、顺铂和伊立替康的半抑制浓度(half maximal inhibitory concentration,IC50)分别为87.57、43.49、18.11和2.43μmol/L,均大于FU97-AFP^(Low)细胞,后者分别为77.19、38.14、16.76和0.94μmol/L。小鼠皮下成瘤实验显示,接种第40天时FU97-AFP^(High)细胞注射点形成皮下瘤,而FU97-AFP^(Low)注射点未见成瘤迹象。RNA-seq及富集分析显示,FU97-AFP^(High)细胞的磷酯酰肌醇3激酶(phosphatidylinositol 3 kinase,PI3K)-Akt、Hippo-YAP、Wnt和转化生长�Objective To explore the regulatory mechanism of alpha fetoprotein(AFP)expression in alpha-fetoprotein-producing gastric cancer(AFPGC)cells and the relationship between AFP expression and tumor malignant phenotype.Methods Using human AFPGC cell line FU97,eighteen monoclones(M1-M18)were established by subclonal sorting technology.Western blot and fluorescence real-time quantitative polymerase chain reaction(RT-qPCR)were used to detect AFP expression.Monoclones with the highest and lowest AFP expression were selected and notated as FU97-AFP^(High)and FU97-AFP^(Low),respectively.Wound-healing assay,epithelial-mesenchymal tran-sition(EMT)biomarker detection,cytotoxicity experiment and subcutaneous NSG mouse model assay were performed to compare the malignant phenotypes of two monoclones.RNA-seq was used to detect the genes with differential expressions in FU97-AFP^(High)and FU97-AFP^(Low)cells,and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment was performed to reveal the pivotal changes of signaling pathways,the result of which was validated by using verteporfin,a small molecular inhibitor of Yes-associated protein 1(YAP1).Results Western blot showed significant differences in AFP expression among M1-M18 monoclones,and monoclones M8(FU97-AFP^(Low))and M12(FU97-AFP^(High))had the minimum and maximum AFP expressions.RT-qPCR showed that the AFP expressions of FU97-AFP^(Low)and FU97-AFP^(High)monoclones were(38.70±3.37)and(3.33±0.04),respectively(P<0.01).The migration of FU97-AFP^(High)cells was greater than FU97-AFP^(Low)cells(P<0.01),with higher expression of N-cadherin and lower expression of E-cadherin protein.Cytotoxicity assay showed that the half maximal inhibitory concentrations(IC50)of FU97-AFP^(High)cells for 5-fluorouracil,docetaxel,cisplatin,and irinotecan were 87.57,43.49,18.11 and 2.43μmol/L,higher than those of FU97-AFP^(Low)cells which were 77.19,38.14,16.76 and 0.94μmol/L,respectively.Subcutaneous NSG mouse model assay showed tumor formation at the injection point of FU97-AFP^(High)cells on
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...